z-logo
open-access-imgOpen Access
Calcium in the heart: when it's good, it's very very good, but when it's bad, it's horrid
Author(s) -
H. Llewelyn Roderick,
Daniel R. Higazi,
Ioannis Smyrnias,
C Fearnley,
Dagmar Harzheim,
Martin D. Bootman
Publication year - 2007
Publication title -
biochemical society transactions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.562
H-Index - 144
eISSN - 1470-8752
pISSN - 0300-5127
DOI - 10.1042/bst0350957
Subject(s) - medicine , contraction (grammar) , heart failure , cardiology , cardiac myocyte , calcium , muscle hypertrophy , myocyte , cardiac hypertrophy , cardiac function curve , cardiac pacemaker , heart disease , endocrinology , chemistry
Ca(2+) increases in the heart control both contraction and transcription. To accommodate a short-term increased cardiovascular demand, neurohormonal modulators acting on the cardiac pacemaker and individual myocytes induce an increase in frequency and magnitude of myocyte contraction respectively. Prolonged, enhanced function results in hypertrophic growth of the heart, which is initially also associated with greater Ca(2+) signals and cardiac contraction. As a result of disease, however, hypertrophy progresses to a decompensated state and Ca(2+) signalling capacity and cardiac output are reduced. Here, the role that Ca(2+) plays in the induction of hypertrophy as well as the impact that cardiac hypertrophy and failure has on Ca(2+) fluxes will be discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom